Pluristem Therapeutics Inc (PSTI)

[zzaatt]

Here's why we're up!

The news is not about Pluristem, BUT it's one more strong indication that stem cells have a tremendous potential. As I always said, any proof of concept, even if not done by Pluristem is very positive for us.

https://www.jpost.com/health-science/10-serious-covid-patients-given-israeli-drug-leave-hospital-in-one-day-669564


The company, Bonus BioGroup, presented the preliminary findings of its Phase I/II trial to peers at the International Society for Cell & Gene Therapy conference in New Orleans last week and shared the results in a statement released to the Tel Aviv Stock Exchange.

Bonus’s MesenCure, which consists of activated Mesenchymal Stromal Cells (MSCs) that are isolated from the adipose tissue of healthy donors, was found to reduce inflammation and alleviate respiratory and other symptoms in patients suffering from life-threatening respiratory distress brought on by COVID-19.
“So far, the results of the treatment with the drug MesenCure are extremely impressive and an improvement over the results of other treatments,” said Dr. Shadi Hamoud, principal investigator in the clinical trial and deputy director of the Department of Internal Medicine E at Rambam.